Company Info
Phone(406) 756-0240
Year Established
2009
Contacts
Matthews O. Bradley, Ph.D.Founder, Chair, President & CEO
Helen S. Pentikis, Ph.D.
Co-Founder, CEO & CSO
Richard J. Pariza, Ph.D.
Senior VP, Chemistry
Company Description
SAJE Pharma has discovered a novel core structure that has been elaborated to produce numerous second and third generation GSNOR inhibitors that are novel compositions of matter with nanomolar IC50ﾒs and potent therapeutic activity by oral, topical, I.V., inhalation, intravitreal, and I.P. routes of administration.
